Qi‐Nian Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Inflammasome and immune disorders
Papers in
-
- RNA modifications and cancer 11
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 9
- Cancer Genomics and Diagnostics 3
- Co-authors
- Rui‐Hua Xu (26 shared papers)Zexian Liu (19 shared papers)Huai‐Qiang Ju (17 shared papers)Zhao-Lei Zeng (18 shared papers)Heng‐Ying Pu (7 shared papers)Kun Liao (3 shared papers)Peishan Hu (6 shared papers)Qi Zhao (12 shared papers)
In The Last Decade
Qi‐Nian Wu
32 papers receiving 1.2k citations
Qi‐Nian Wu's Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 403
- Molecular Biology 660
- Oncology 208
- Immunology 137
- Pulmonary and Respiratory Medicine 191
Countries citing papers authored by Qi‐Nian Wu
This map shows the geographic impact of Qi‐Nian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Nian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Nian Wu more than expected).
Fields of papers citing papers by Qi‐Nian Wu
This network shows the impact of papers produced by Qi‐Nian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Nian Wu. The network helps show where Qi‐Nian Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi‐Nian Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis Hit paper breakdown → | 2022 | 242 |
| 2 | 2011 | 141 | |
| 3 | 2019 | 104 | |
| 4 | 2020 | 85 | |
| 5 | 2023 | 84 | |
| 6 | 2021 | 60 | |
| 7 | CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases Hit paper breakdown → | 2024 | 59 |
| 8 | 2020 | 48 | |
| 9 | 2023 | 48 | |
| 10 | 2022 | 40 | |
| 11 | 2019 | 40 | |
| 12 | 2017 | 38 | |
| 13 | 2023 | 31 | |
| 14 | 2021 | 30 | |
| 15 | 2022 | 24 | |
| 16 | 2022 | 18 | |
| 17 | 2024 | 18 | |
| 18 | 2018 | 16 | |
| 19 | 2012 | 16 | |
| 20 | 2017 | 13 |
About Qi‐Nian Wu
Qi‐Nian Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pathology and Forensic Medicine, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (9 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (3 papers), Genetic factors in colorectal cancer (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (403 citations), Molecular Biology (660 citations), Oncology (208 citations), Immunology (137 citations) and Pulmonary and Respiratory Medicine (191 citations). Qi‐Nian Wu has collaborated with scholars based in China, Hong Kong and Austria. Frequent co-authors include Rui‐Hua Xu, Zexian Liu, Huai‐Qiang Ju, Zhao-Lei Zeng, Heng‐Ying Pu, Kun Liao, Peishan Hu, Qi Zhao, Jin‐Fei Lin and Miao‐Zhen Qiu. Their work appears in journals such as Cancer Letters, Signal Transduction and Targeted Therapy, Oncogene, Cancer Research and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.